Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q1 2025 Earnings Conference Call May 8, 2025 2:00 PM ET
Company Participants
Mark Kawakami – Chief Financial Officer
T.J. Schaefer – President and Chief Executive Officer
Conference Call Participants
Ben Klee – Lake Street
Operator
Hello, and welcome to Arcadia Biosciences First Quarter 2025 Financial Results and Business Highlights Conference Call.
At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded.
I would now like to hand the conference over to Mark Kawakami, Chief Financial Officer at Arcadia. Please go ahead.
Mark Kawakami
Thank you. Joining me on the call today is T.J. Schaefer, Arcadia’s President and Chief Executive Officer. This call is being webcast, and you can refer to the company’s press release at arcadiabio.com.
Before we start, we would like to remind you that Arcadia Biosciences will be making forward-looking statements on this call based on current expectations and currently available information. However, since these statements are based on factors that involve risks and uncertainties, the company’s actual performance and results may differ materially from those described or implied today. You can review the company’s Safe Harbor language and our most recently filed 10-K.
With that, I’ll now turn the call over to, T.J.
T.J. Schaefer
Thanks, Mark, and thank you to everyone on the call for joining us today to discuss our 2025 first quarter financial results.
It has only been seven weeks since we delivered our 2024 year-end update, but the momentum from the second half of 2024 has carried into 2025, and I am very pleased with our first quarter results. Zola coconut water continues to thrive and outperform our own internal expectations.
In Q1 2025, our reported Zola sales
#Arcadia #Biosciences #RKDA #Earnings #Call #Transcript